In line, many cancer cells including the prostate cancer cell line PC-3 (Ismail et al., 1999; Qyang et al., 1999) displayed a loss of USF2 transcriptional activity while it was active in non-tumorigenic cells. This evidence concerns the gene USF2 and cancer.